11th meeting of the Elekta MR-linac Consortium convenes in Manchester, UK, with impressive momentum on breakthrough technology
Seventeen institutions seamlessly combine world-class expertise to advance magnetic resonance radiation therapy (MR/RT) and transform cancer careSTOCKHOLM, April 5, 2018 – Elekta (EKTA-B.ST) today provided an update on the 11th meeting of the Elekta MR-linac Consortium, which was held March 22 – 24 at The Christie NHS Foundation Trust in Manchester, UK. The four-day Consortium meeting was attended by 180 world-class researchers and clinicians from seventeen institutions, including the founding centers and 10 new ones. The Elekta MR-linac Consortium is a collaborative industrial-academic